Qube Research & Technologies Ltd

Position in PLRX — Pliant Therapeutics, Inc.

CIK 1729829 LONDON, X0

Position in PLRX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$13,817

-$5,001 QoQ

Shares Held

10,966

-28.9% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Qube Research & Technologies Ltd holds $2,030,593,180 across 187 Biotechnology names. PLRX ranks #187 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	838,187	$277,330,932
2	FOLD	AMICUS THERAPEUTICS, INC.	8,809,340	$127,383,056
3	ROIV	Roivant Sciences Ltd.	3,450,904	$95,590,040
4	RPRX	Royalty Pharma plc	1,524,511	$73,130,792
5	REGN	Regeneron Pharmaceuticals, Inc.	83,358	$64,405,725
6	AXSM	Axsome Therapeutics, Inc.	335,334	$56,678,152
7	RVMD	Revolution Medicines, Inc.	553,290	$53,807,452
8	CYTK	Cytokinetics Inc	779,446	$51,373,285

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$13,817	10,966	-28.9%	Shares	Sole	2026-05-15
2025-12-31	$18,818	15,425	-68.8%	Shares	Sole	2026-02-17
2025-09-30	$73,282	49,515	-67.4%	Shares	Sole	2025-11-14
2025-06-30	$175,927	151,662	+104.9%	Shares	Sole	2025-08-14
2023-06-30	$1,341,333	74,025	-57.9%	Shares	Sole	2023-08-14
2023-03-31	$4,678,275	175,875	+128.2%	Shares	Sole	2023-05-15
2022-12-31	$1,489,763	77,070	+186.5%	Shares	Sole	2023-02-14
2022-09-30	$561,961	26,901	+99.9%	Shares	Sole	2022-11-14
2022-06-30	$107,806	13,459	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.